MatchBio
Regenerative Medicine · Cell & Gene Therapy
Overview
Making the right match between immune cells and their targets to transform immunotherapy. Looking to partner or learn more about MatchBio?
Funding and backers
Backers
1
Oxford Science Enterprises
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Building programmable in vivo immune-cell therapies across oncology and autoimmune disease.
Avigen develops cellular avidity tools for immunotherapy and cell therapy R&D, helping identify potent and safe lead drug candidates faster.
Circio Holding ASA (OSE:TRVX, to be changed to CRNA), a biotechnology company developing novel circular RNA and immunotherapy medicines.
Shinobi Therapeutics is transforming cell therapy with scalable, immune-evasive iPSC-derived treatments for cancer and autoimmune diseases.
セレイドセラピューティクス - 細胞治療(造血幹細胞). Change the futurewith cell therapy.
Gentle and Automated Single-Cell Technologies. iotaSciences offers efficient automation solutions for gentle single-cell isolation and…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Oxford Science EnterprisesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely